Clear-cell renal cell carcinoma - A comprehensive review of agents used in the contemporary management of advanced/metastatic disease

por Gkolfinopoulos, Stavros, Psyrri, Amanda, Bamias, Aristotelis
Publicado 2021

The Emerging Role of Platelets in the Formation of the Micrometastatic Niche: Current Evidence and Future Perspectives

por Gkolfinopoulos, Stavros, Jones, Robin L., Constantinidou, Anastasia
Publicado 2020

Chromogranin A as a valid marker in oncology: Clinical application or false hopes?

por Gkolfinopoulos, Stavros, Tsapakidis, Konstantinos, Papadimitriou, Konstantinos, Papamichael, Demetris, Kountourakis, Panteleimon
Publicado 2017

Advances in molecular, genetic and immune signatures of gastric cancer: Are we ready to apply them in our patients’ decision making?

por Gkolfinopoulos, Stavros, Papamichael, Demetris, Papadimitriou, Konstantinos, Papanastasopoulos, Panos, Vassiliou, Vassilios, Kountourakis, Panteleimon
Publicado 2018

P915: EFFICACY AND SAFETY OF DARATUMUMAB MONOTHERAPY IN NEWLY DIAGNOSED PATIENTS WITH STAGE 3B LIGHT CHAIN AMYLOIDOSIS: A PHASE 2 STUDY BY THE EUROPEAN MYELOMA NETWORK

por Kastritis, E., Minnema, M. C., Dimopoulos, M. A., Merlini, G., Theodorakakou, F., Fotiou, D., Huart, A., Belhadj, K., Gkolfinopoulos, S., Manousou, K., Sonneveld, P., Palladini, G.
Publicado 2022

P914: EFFICACY AND SAFETY OF BELANTAMAB MAFODOTIN MONOTHERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY LIGHT CHAIN AMYLOIDOSIS: A PHASE 2 STUDY BY THE EUROPEAN MYELOMA NETWORK

por Kastritis, E., Palladini, G., Dimopoulos, M. A., Jaccard, A., Merlini, G., Theodorakakou, F., Fotiou, D., Minnema, M. C., Wechalekar, A., Gkolfinopoulos, S., Manousou, K., Sonneveld, P., Schönland, S.
Publicado 2022

P901: DARATUMUMAB, IXAZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA PRE-TREATED WITH A LENALIDOMIDE-BASED REGIMEN: FINAL OUTCOMES OF THE PHASE 2 DAR...

por Terpos, Evangelos, Gavriatopoulou, Maria, Katodritou, Eirini, Hatjiharissi, Evdoxia, Dialoupi, Ioanna, Verrou, Evgenia, Manousou, Kyriaki, Gkolfinopoulos, Stavros, Migkou, Magdalini, Delimpasi, Sosana, Symeonidis, Argiris, Kastritis, Efstathios, Dimopoulos, Meletios A.
Publicado 2023

P884: BELANTAMAB MAFODOTIN PLUS LENALIDOMIDE AND DEXAMETHASONE IN TRANSPLANT INELIGIBLE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA: UPDATED RESULTS FROM THE PHASE 1/2 BELARD ST...

por Terpos, Evangelos, Gavriatopoulou, Maria, Ntanasis-Stathopoulos, Ioannis, Malandrakis, Panagiotis, Fotiou, Despina, Migkou, Magdalini, Theodorakakou, Foteini, Spiliopoulou, Vasiliki, Syrigou, Rodanthi, Eleutherakis-Papaiakovou, Evangelos, Gkolfinopoulos, Stavros, Manousou, Kyriaki, Kastritis, Efstathios, Dimopoulos, Meletios A.
Publicado 2023

P928: OCULAR ADVERSE EVENTS AND FUNCTIONAL IMPACT IN TRANSPLANT INELIGIBLE, NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS TREATED WITH BELANTAMAB MAFODOTIN, LENALIDOMIDE AND DEXAMETHAS...

por Terpos, Evangelos, Ntanasis-Stathopoulos, Ioannis, Gavriatopoulou, Maria, Malandrakis, Panagiotis, Fotiou, Despina, Migkou, Magdalini, Theodorakakou, Foteini, Spiliopoulou, Vasiliki, Syrigou, Rodanthi, Eleutherakis-Papaiakovou, Evangelos, Gkolfinopoulos, Stavros, Manousou, Kyriaki, Kastritis, Efstathios, Dimopoulos, Meletios A.
Publicado 2023

P14 OCULAR TOXICITY IN TRANSPLANT INELIGIBLE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA TREATED WITH BELANTAMAB MAFODOTIN, LENALIDOMIDE AND DEXAMETHASONE IN A PHASE 1/2 TRIAL

por Ntanasis-Stathopoulos, I., Gavriatopoulou, M., Malandrakis, P., Fotiou, D., Kanellias, N., Migkou, M., Theodorakakou, F., Spiliopoulou, V., Syrigou, R., Eleutherakis-Papaiakovou, E., Gkolfinopoulos, S., Manousou, K., Kastritis, E., Dimopoulos, M.A., Terpos, E.
Publicado 2023

Response of Practicing Chiropractors during the Early Phase of the COVID-19 Pandemic: A Descriptive Report

por Johnson, Claire D., Green, Bart N., Konarski-Hart, Karen K., Hewitt, Elise G., Napuli, Jason G., Foshee, William K., Brown, Jason W., Kopansky-Giles, Deborah, Stuber, Kent J., Lerede, Caterina, Charlton, Scott T., Field, Jonathan R., Botelho, Marcelo B., Da Silva, Kendrah L., Tønner, Gitte, Yap, Terrence BK., Gkolfinopoulos, Vasileios S., Quintero, Gabriel, Agaoglu, Mustafa H.
Publicado 2020

Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer

por Moutafi, Myrto, Koliou, Georgia-Angeliki, Papaxoinis, George, Economopoulou, Panagiota, Kotsantis, Ioannis, Gkotzamanidou, Maria, Anastasiou, Maria, Pectasides, Dimitrios, Kyrodimos, Efthymios, Delides, Alexander, Giotakis, Evangelos, Papadimitriou, Nikolaos G., Panayiotides, Ioannis G., Perisanidis, Christos, Fernandez, Aileen I., Xirou, Vasiliki, Poulios, Christos, Gagari, Eleni, Yaghoobi, Vesal, Gavrielatou, Niki, Shafi, Saba, Aung, Thazin Nwe, Kougioumtzopoulou, Andromachi, Kouloulias, Vassilis, Palialexis, Konstantinos, Gkolfinopoulos, Stavros, Strati, Areti, Lianidou, Evi, Fountzilas, George, Rimm, David L., Foukas, Periklis G., Psyrri, Amanda
Publicado 2023